Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
Developed in 1996, 1997 and 2001 respectively.
The original 62-item-version of Skindex cannot be used.
An adolescent version also exists: Skindex-Teen.
Skindex-29 is a revised 29-items version of Skindex. Skindex-16 is a single-page version of Skindex.
Generic for Skin and Connective Tissue Diseases
Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996 Nov;107(5):707-13 (PubMed abstract)
Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol. 1997 Jan;108(1):103-7 (PubMed abstract)
Chren MM, Lasek RJ, Flock SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997 Nov;133:1433,1440 (PubMed abstract)
Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement of properties of skindex-16, a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001 Mar-Apr;5(2):105-10 (PubMed abstract)
University of California at San Francisco
2340 Sutter Street, N412
Mail Code: Box 0808
San Francisco, CA 94143-0808
Fax: +1 (415) 476-6751
Mary-Margaret Chren publications (PubMed)
Mapi Research Trust
27 rue de la Villette
Phone: +33 (0)4 72 13 66 66
Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.
Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
Leplege A, Ecosse E, Zeller J, Revuz J, Wolkenstein P. [The French version of Skindex (Skindex-France). Adaptation and assessment ofpsychometric properties] Ann Dermatol Venereol. 2003 Feb;130(2 Pt 1):177-83. French
Augustin M, Wenninger K, Amon U, Schroth MJ, Kuster W, Chren M, Kupfer J, Gieler U. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results. Dermatology. 2004;209(1):14-20
Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology. 2002;204(1):43-9
Jones-Caballero M, Penas PF, Garcia-Diez A, Chren MM, Badia X. [The Spanish version of Skindex-29. An instrument for measuring quality of life in patients with cutaneous diseases] Med Clin (Barc). 2002 Jan 19;118(1):5-9. Spanish
Jones-Caballero M, Penas PF, Garcia-Diez A, Badia X, Chren MM. The Spanish version of Skindex-29. Int J Dermatol. 2000 Dec;39(12):907-12
Alghamdi KM, Alshammari SA. Arabic version of Skindex-16: Translation and cultural adaptation, with assessment of reliability and validity. Int J Dermatol. 2007 Mar;46(3):247-52